HealthcareServices

Global Smart Drug Delivery Systems Market Report 2026–2030: Data-Driven Growth Insights

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the smart drug delivery systems market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Smart Drug Delivery Systems Market’s size between 2026 and 2030?

The smart drug delivery systems market size has seen significant expansion in recent years. Its valuation is anticipated to increase from $15.06 billion in 2025 to $18 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.5%. The market’s historic growth is attributable to factors such as the limitations of conventional drug delivery, the rise in chronic diseases, advancements in biomaterials, a greater emphasis on improved patient adherence, and ongoing pharmaceutical innovation.

The market for smart drug delivery systems is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $33.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.5%. Contributing factors to this growth during the forecast period include the increasing demand for personalized therapies, wider adoption of biologics, the integration of digital health solutions, favorable regulatory backing for combination devices, and advancements in nanotechnology. Key trends anticipated during the forecast timeframe encompass the incorporation of AI-controlled dosing, the proliferation of implantable delivery systems, a heightened need for targeted drug delivery, the implementation of wireless connectivity, and the broadening of combination drug-device product offerings.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14796&type=smp

Which Drivers Are Shaping Strategic Decisions In The Smart Drug Delivery Systems Market?

The smart drug delivery systems market is projected to grow due to the increasing incidence of chronic diseases. These are long-standing health conditions that gradually advance over time and frequently stem from intricate origins. The escalation in chronic disease prevalence is attributed to an aging populace, environmental factors, and inequalities in healthcare accessibility. Smart drug delivery systems present a promising strategy for managing chronic diseases by boosting medication effectiveness and fostering greater patient adherence. For instance, data from April 2025, provided by the Centers for Disease Control and Prevention (CDC), a U.S. federal agency, indicated that in 2023, around 194 million U.S. adults, or 76.4%, reported experiencing at least one chronic condition. The prevalence stood at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the rising occurrence of chronic diseases is a key driver for the smart drug delivery systems market.

What Segment Categories Are Covered In The Smart Drug Delivery Systems Market?

The smart drug delivery systems market covered in this report is segmented –

1) By Product: Connected Inhalers, Connected Autoinjectors, Connected Pen Injectors, Connected Wearable Injectors, Add-On Sensors, Other Products

2) By Therapeutic Area: Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Hormonal Disorders, Other Therapeutic Areas

3) By Drug Delivery Mode: Injectable, Inhalation, Oral Drug Delivery Systems

4) By End-User: Hospitals, Clinics, Home Care, Ambulatory Care Settings, Other End-Users

Subsegments:

1) By Connected Inhalers: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)

2) By Connected Autoinjectors: Single-Dose Autoinjectors, Multi-Dose Autoinjectors

3) By Connected Pen Injectors: Insulin Pen Injectors, Biologic Pen Injectors

4) By Connected Wearable Injectors: Insulin Wearable Injectors, Infusion Pump Wearable Injectors

5) By Add-On Sensors: Glucose Monitoring Sensors, Medication Adherence Sensors, Temperature Sensors

6) By Other Products: Smart Syringes, Smart Patches, Smart Implants

Which Innovation Trends Are Advancing Developments Within The Smart Drug Delivery Systems Market?

Companies operating within the Smart Drug Delivery Systems market are concentrating on developing innovative solutions, such as advanced on-body delivery platforms, to enhance the administration of injectable therapies, improve patient convenience, and ensure precise dosing. These advanced on-body delivery platforms are wearable systems designed to automatically and accurately deliver medication over time, thus improving convenience, safety, and adherence to treatment. For instance, in October 2024, Stevanato Group, an Italy-based pharmaceutical solutions provider, introduced its large-volume Vertiva 10 mL on-body delivery system platform at CPHI Milan. The platform is engineered to support high-volume injectable therapies, offering improved usability, safety, and treatment adherence, which addresses the growing demand for patient-centric drug delivery solutions.

Which Key Players Are Driving Competition In The Smart Drug Delivery Systems Market?

Major companies operating in the smart drug delivery systems market are Johnson & Johnson, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Novo Nordisk, Becton Dickinson and Company, Baxter International Inc, Phillips-Medisize Corporation, ResMed Inc, West Pharmaceutical Services Inc, Insulet Corporation, Owen Mumford Ltd, Sonceboz, H&T Presspart Manufacturing Ltd, E3D Elcam Drug Delivery Devices, CeQur Corporation, Ypsomed Holding AG, Nemera, Gerresheimer AG, Haselmeier AG, SHL Medical, Aptar Pharma

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report

Which Region Is Projected To Lead The Smart Drug Delivery Systems Market During The Forecast Period?

North America was the largest region in the smart drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Smart Drug Delivery Systems Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14796&type=smp

Browse Through More Reports Similar to the Global Smart Drug Delivery Systems Market 2026, By The Business Research Company

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Electronic Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report

Advanced Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795